BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36717863)

  • 1. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
    Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
    Radiat Oncol; 2023 Jan; 18(1):21. PubMed ID: 36717863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients.
    Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Mazzara C; Cebula H; Noel G; Antoni D
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.
    Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Bund C; Chambrelant I; Antoni D; Noel G
    Strahlenther Onkol; 2022 Jun; 198(6):527-536. PubMed ID: 35294567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
    Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
    Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients.
    Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
    Radiat Oncol; 2023 Jan; 18(1):7. PubMed ID: 36627646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glasgow prognostic score for assessing the efficacy of whole-brain radiation therapy in cases of recursive partitioning analysis class 2 and class 3 multiple brain metastases: a retrospective study.
    Ishikawa Y; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Suzuki Y; Kishida K; Omata S; Teramura S; Ito K; Yamada T; Jingu K
    Acta Neurol Belg; 2024 Feb; 124(1):231-239. PubMed ID: 37747688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
    Saginc H; Baltalarli PB; Sagtas E; Coskun ME
    Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
    Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
    J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
    Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
    Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upfront stereotactic radiosurgery in patients with brain metastases from small cell lung cancer: retrospective analysis of 41 patients.
    Yomo S; Hayashi M
    Radiat Oncol; 2014 Jul; 9():152. PubMed ID: 25005424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
    Holub K; Louvel G
    Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Bernhardt D; König L; Aufderstrasse S; Krisam J; Hoerner-Rieber J; Adeberg S; Bozorgmehr F; El Shafie R; Lang K; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Marcrom S; Debus J; Steins M; Rieken S
    Clin Lung Cancer; 2018 Jul; 19(4):340-345. PubMed ID: 29373273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity.
    Fritz C; Borsky K; Stark LS; Tanadini-Lang S; Kroeze SGC; Krayenbühl J; Guckenberger M; Andratschke N
    Front Oncol; 2018; 8():551. PubMed ID: 30524969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.